Skip to main content
Premium Trial:

Request an Annual Quote

PathoFinder Obtains CE Mark for Two Multiplex SARS-CoV-2 MDx Tests

NEW YORK – Dutch molecular diagnostics developer PathoFinder has received CE IVD marking for two multiplex PCR tests for SARS-CoV-2 and other respiratory pathogens.

Specifically, the Maastricht-based firm obtained CE marking for the RespiFinder 2Smart kit for SARS-CoV-2 and Middle East respiratory syndrome-related coronavirus (MERS-CoV) testing, as well as for the RealAccurate Quadriplex (RAQ) Flu/COVID-19 PCR kit.

PathoFinder said that the RespiFinder 2Smart kit now detects 24 respiratory pathogens simultaneously using the company's proprietary 2SmartFinder technology. The SARS-CoV-2 N gene and MERS-CoV E gene were selected as targets to detect these additional viruses.

Meanwhile, the RAQ Flu/COVID-19 PCR kit detects and differentiates influenza A, influenza B, and SARS-CoV-2 (using the N gene and RdRp gene) from nasopharyngeal swabs.

PathoFinder received CE marking in April for its RealAccurate Quadruplex Corona-plus PCR kit for detecting SARS-CoV-2 from nasopharyngeal and oropharyngeal swabs, and in June for its RealAccurate Quadruplex SARS-CoV-2 PCR kit for detecting viral RNA by targeting the N and RdRp genes.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.